Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Zivanovic

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytomaV J Lewington, M A Zivanovic, M Tristam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefitM Tristam, A S Alaamer, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1988
Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytomaG M Blake, V J Lewington, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1987
89Sr radionuclide therapy: dosimetry and haematological toxicity in two patients with metastasising prostatic carcinomaG M Blake, M A Zivanovic, A J McEwan, et al.
European Journal of Nuclear Medicine|January 1, 1989
89Sr therapy: strontium plasma clearance in disseminated prostatic carcinomaG M Blake, J F Wood, P J Wood, et al.
The British Journal of Radiology|March 1, 1987
Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcomaG M Blake, M A Zivanovic, A J McEwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1988
Strontium-89 therapy: measurement of absorbed dose to skeletal metastasesG M Blake, M A Zivanovic, R M Blaquiere, et al.
The British Journal of Radiology|July 1, 1987
Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysisG M Blake, J M Gray, M A Zivanovic, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneV J Lewington, A J McEwan, D M Ackery, et al.
The British Journal of Radiology|September 1, 1991
Strontium-89 chloride for pain palliation in prostatic skeletal malignancyA H Laing, D M Ackery, R J Bayly, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytomaV J Lewington, M A Zivanovic, M Tristam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefitM Tristam, A S Alaamer, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1988
Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytomaG M Blake, V J Lewington, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1987
89Sr radionuclide therapy: dosimetry and haematological toxicity in two patients with metastasising prostatic carcinomaG M Blake, M A Zivanovic, A J McEwan, et al.
European Journal of Nuclear Medicine|January 1, 1989
89Sr therapy: strontium plasma clearance in disseminated prostatic carcinomaG M Blake, J F Wood, P J Wood, et al.
The British Journal of Radiology|March 1, 1987
Strontium-89 therapy: strontium kinetics and dosimetry in two patients treated for metastasising osteosarcomaG M Blake, M A Zivanovic, A J McEwan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1988
Strontium-89 therapy: measurement of absorbed dose to skeletal metastasesG M Blake, M A Zivanovic, R M Blaquiere, et al.
The British Journal of Radiology|July 1, 1987
Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysisG M Blake, J M Gray, M A Zivanovic, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to boneV J Lewington, A J McEwan, D M Ackery, et al.
The British Journal of Radiology|September 1, 1991
Strontium-89 chloride for pain palliation in prostatic skeletal malignancyA H Laing, D M Ackery, R J Bayly, et al.
Pageof 3